Cyclophosphamide Monohydrate Market

Cyclophosphamide Monohydrate is niche oncology API used for the treatment of malignant lymphomas (Stages III and IV of the Ann Arbor staging system), Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), mixed-cell type lymphoma, histiocytic lymphoma, Burkitt's lymphoma. multiple myeloma.. Available for all global markets except the US along with DMF support. Available as both sterile grade (for injectables) and non-sterile grade (for tablets)
Cyclophosphamide Monohydrate Market contains market size and forecasts of Cyclophosphamide Monohydrate in global, including the following market information:
Global Cyclophosphamide Monohydrate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cyclophosphamide Monohydrate Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Cyclophosphamide Monohydrate companies in 2021 (%)
The global Cyclophosphamide Monohydrate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sterile Grade Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cyclophosphamide Monohydrate include Baxter Healthcare, Evonik Industries, Jiangsu Hengrui Medicine, Fermion Oy, Orion Corporation, American Pacific Corporation, Apothecon Pharmaceuticals, Hetero Drugs Limited and Aarti Industries, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cyclophosphamide Monohydrate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cyclophosphamide Monohydrate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Cyclophosphamide Monohydrate Market Segment Percentages, by Type, 2021 (%)
Sterile Grade
Non-sterile Grade
Global Cyclophosphamide Monohydrate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Cyclophosphamide Monohydrate Market Segment Percentages, by Application, 2021 (%)
Injection
Tablets
Global Cyclophosphamide Monohydrate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Cyclophosphamide Monohydrate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cyclophosphamide Monohydrate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cyclophosphamide Monohydrate revenues share in global market, 2021 (%)
Key companies Cyclophosphamide Monohydrate sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Cyclophosphamide Monohydrate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter Healthcare
Evonik Industries
Jiangsu Hengrui Medicine
Fermion Oy
Orion Corporation
American Pacific Corporation
Apothecon Pharmaceuticals
Hetero Drugs Limited
Aarti Industries
Nishchem International
Olainfarm JSC
Jiwan Pharmaceutical Technology